Title |
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial |
|---|---|
Involved |
Anne Katrin Berger (Verfasser)
Carl von Gall (Mitwirkender) Ulrich Abel (Mitwirkender) Stefan Delorme (Mitwirkender)
Matthias Kloor (Mitwirkender)
Jennifer Ose (Mitwirkender) Tim Weber (Mitwirkender) Annika Stange (Mitwirkender) Georg Martin Haag (Mitwirkender) Uwe Haberkorn (Mitwirkender) Florian Lordick (Mitwirkender) Dirk Jäger (Mitwirkender) SpringerLink (Online service) (Herausgebendes Organ) |
Published in |
BMC cancer 12, 1, 22.3.2012, date:12.2012, Seite 1-6 |
Published |
2012 |
Language |
|
Country |
|
Subject |
Biomedicine. |
Persistent identifier |
urn:nbn:de:1111-201603041571 (URN) |
Record ID |
1085332780 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: